Recurrent epistaxis after treatment with tadalafil (Cialis)

Acta Oto-Laryngologica

Volumn 125, Issue 3, 2005, Pages 334-335

  Ismail, H ^a,b   Harries, P G ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b MRCS   (United Kingdom)

Author keywords

Cialis; Epistaxis; Sildenafil; Tadalafil; Viagra

Indexed keywords

SILDENAFIL; TADALAFIL;

AGED; ARTICLE; BACKACHE; CASE REPORT; DIZZINESS; DRUG MECHANISM; DYSPEPSIA; EPISTAXIS; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HUMAN; HYPOTENSION; MALE; MYALGIA; NOSE CONGESTION; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SEXUAL BEHAVIOR; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE;

AGED; CARBOLINES; EPISTAXIS; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; RECURRENCE;

EID: 16444378327     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410022912     Document Type: Article

References (6)

1. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002;168:1332-6.
2. Minhas S, Kalsi JS, Ralph DJ. Cialis (tadalafil): a new treatment for erectile dysfunction. Hosp Med 2003;64:589-92.
3. Eardley I, Cartledge J. Tadalafil (Cialis) for men with erectile dysfunction. Int J Clin Pract 2002;56:300-4.
4. Hicklin LA, Ryan C, Wong DKK, Hinton AE. Nose-bleeds after sildenafil (Viagra). J R Soc Med 2002;95:402-3.
5. Bott SRJ, Shergill I, Arya M. Epistaxis after sildenafil. J R Soc Med 2002;95:528.
6. Tzathas C, Christidou A, Ladas S. Sildenafil (viagra) is a risk factor for acute variceal bleeding. Am J Gastroenterol 2002;97:1856.